ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Clinical practice"

  • Abstract Number: 580 • 2015 ACR/ARHP Annual Meeting

    Treatment with Biologic Agents in Rheumatoid Arthritis and Mortality Risk in Clinical Practice

    Leticia Leon1, Luis Rodriguez-Rodriguez1, Alejandro Gomez-Gomez2, Pilar Macarrón2, Margarita Blanco2, Juan A Jover2 and Lydia Abasolo1, 1Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain, 2Rheumatology, Hospital Clínico San Carlos, Madrid, Spain

    Background/Purpose: It is a well-known fact the decline of life expectancy in Rheumatoid Arthritis (RA) being the increased mortality in these patients a constant concern…
  • Abstract Number: 682 • 2015 ACR/ARHP Annual Meeting

    Misalignment Between Physician and Patient Satisfaction with Current Psoriatic Arthritis Treatment

    Daniel E. Furst1, Emma Sullivan2, James Pike3, James Piercy4, Jacqueline Palmer5 and Vivian Herrera5, 1Medicine, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA, 2Adelphi Real World, Manchester, United Kingdom, 3Statistics, Adelphi Real World, Macclesfield, United Kingdom, 4Adelphi Real World, Macclesfield, United Kingdom, 5Novartis Pharmaceuticals Corporation, East Hanover, NJ

    Background/Purpose: Psoriatic Arthritis (PsA) is a chronic immune related condition affecting the joints and commonly occurs alongside psoriasis. Well-established physician patient relationships are instrumental to…
  • Abstract Number: 1276 • 2015 ACR/ARHP Annual Meeting

    Improvement in Work and Household Productivity for Patients with Rheumatoid Arthritis and Ankylosing Spondylitis Treated with Anti-TNFs in Routine Clinical Practice in Turkey

    Sebnem Ataman1, Mehmet Kirnap2, Buminhan Seferoglu3, Zuhal Altay4, Aylin Rezvani5, Omer Kuru6,7, Erhan Capkin8, Nazli Derya Bugdayci9, Ilhan Sezer10, Hasan Fatih CAY11 and Akinci Tan12, 1Rheumatology Department, Ankara University Faculty of Medicine, Ankara, Turkey, 2Department of Physical Medicine and Rehabilitation, Erciyes University, Kayseri, Turkey, 3Physical Medicine and Rehabilitation, Ataturk University Medical School, Erzurum, Turkey, 4ELAZIG KARAYOLU UZERI, Inonu University, Turgut Ozal Medical Center, Malatya, Turkey, 5Department of Physical Medicine and Rehabilitation, Bezmialem Foundation University, İstanbul, Turkey, 6Kurupelit Mevkii Kurupelit 552, Ondokuz Mayis Univ.Tip Fak.Has.-Fizik Tedavi, Samsun, Turkey, 7Physical Medicine and Rehabilitation, Ondokuz Mayis University, Samsun, Turkey, 8PM&R AND RHEUMATOLOGY, Karadeniz Tecnical University, Faculty of Medicine, TRABZON, Turkey, 9Physical Treatment and Rehabilitation, Istanbul Physical Treatment and Rehabilitation Training and Research Hospital, Istanbul, Turkey, 10Rheumatology, Physical Medicine and Rheabilitation, Antalya Education and Research Hospital, Antalya, Turkey, 11Rheumatology, Physical Medicine&Rehabilitation, Antalya Education and Research Hospital, Antalya, Turkey, 12Physical Med & Rehab, Hacettepe Univ, Ankara, Turkey

    Background/Purpose: The impact of  rheumatoid arthritis (RA) and ankylosing spondylitis (AS)  on paid work is measured on the basis of employed people missing time from…
  • Abstract Number: 1655 • 2015 ACR/ARHP Annual Meeting

    Effectiveness of Monotherapy in Rheumatoid Arthritis (RA) Patients Initiating a Tumor Necrosis Factor Inhibitor (TNFi) Vs a Non-TNFi in a Large US Commercial and Medicare Advantage Plan

    Benjamin Chastek1, Jeffrey R. Curtis2, Laura K. Becker3, George J. Joseph4 and Chieh-I Chen5, 1Optum Insight, Eden Prairie, MN, 2University of Alabama at Birmingham, Birmingham, AL, 3Optum, Eden Prairie, MN, 4Global Health Economics & Outcomes Research (HEOR), Sanofi, Bridgewater, NJ, 5Regeneron Pharmaceuticals, Inc., Tarrytown, NY

    Background/Purpose: Monotherapy accounts for approximately 30% of biologic disease-modifying anti-rheumatic drug (DMARD) use in RA (Emery P et al. Ann Rheum Dis 2013;72:1897-904). A validated…
  • Abstract Number: 1715 • 2015 ACR/ARHP Annual Meeting

    Sensivity and Specificity of Clinical Criteria to Identify Patients in Ultrasound Remission in Psoriatic Arthritis

    Brigitte Michelsen1, Andreas P Diamantopoulos2, Hilde Berner Hammer3, Arthur Kavanaugh4 and Glenn Haugeberg1,5,6, 1Rheumatology, Hospital of Southern Norway Trust, Kristiansand, Norway, 2Haugesund Rheumatism Hospital, Haugesund, Norway, 3Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 4University of California, San Diego School of Medicine, LaJolla, CA, 5Rheumatology, The Norwegian University of Science and Technology, Trondheim, Norway, 6Rheumatology, Martina Hansens Hospital, Gjettum, Norway

    Background/Purpose: To date, although several have been proposed, there are no validated remission criteria in psoriatic arthritis (PsA). Validated criteria for minimal disease activity (MDA) in…
  • Abstract Number: 1717 • 2015 ACR/ARHP Annual Meeting

    Factors Associated with the Decision of the Rheumatologist to Order Sacro-Iliac Joints Magnetic Resonance Imaging (SI-MRI) or Order HLA-B27 Testing in Patients with Spondyloarthritis in Clinical Practice

    Wilson Bautista-Molano1,2, Robert Landewé3, Cesar Serna4, Rafael R. Valle5 and Désirée van der Heijde6, 1Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands, Leiden, Netherlands, 2Department of Rheumatology, Faculty of Medicine HMC/UMNG, Bogota, Colombia, Bogotá, Colombia, 3Department of Rheumatology, Amsterdam Rheumatology Center, Amsterdam, The Netherlands, Amsterdam, Netherlands, 4Statistics and Mathematics Department, Universidad Central, Bogotá, Colombia, Bogotá, Colombia, 5Rheumatology/Immunology, Department of Rheumatology, Faculty of Medicine HMC/UMNG, Bogota, Colombia, Bogota, Colombia, 6Dept. of Rheumatology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: Magnetic resonance imaging of sacroiliac joints (MRI-SI) and HLA-B27 testing are important tools in the diagnosis of spondyloarthritis (SpA). The aim of the study…
  • Abstract Number: 1977 • 2015 ACR/ARHP Annual Meeting

    Long-Term Survival of Methotrexate in Giant Cell Arteritis Patients in Clinical Practice

    Dalifer Freites Núñez1, Zulema Rosales1,2, Lucía Arietti1, Leticia Leon2, Inmaculada Morado1, Benjamín Fernández-Gutiérrez3, Luis Rodriguez-Rodriguez2, Juan A Jover1 and Lydia Abasolo2, 1Rheumatology, Hospital Clínico San Carlos, Madrid, Spain, 2Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain, 3Department of Rheumatology, Hospital Clínico San Carlos, Madrid, Spain

    Background/Purpose: It has is been demonstrated the safety and efficacy of Methotrexate (MTX) in the treatment of Giant Cell Arteritis (GCA) in clinical trials, but…
  • Abstract Number: 2324 • 2014 ACR/ARHP Annual Meeting

    Only 30% Rheumatologists Collect Basdai in Patients with Axial Spa in Daily Practice: The Potential Role of a Consensual Meeting to Improve It

    Hélène Che1,2, Adrien Etcheto2,3, Emmanuelle Dernis Labous4,5, Henri Nataf5, Patrick Boumier5, Philippe Breuillard5, Marianne Durandin-Truffinet5, Jacques Fechtenbaum2,5, Veronique Gaud-Listrat2,5, Bernard Giraud5, Christophe Hudry2,5, Sylvain La Batide Alanore5, Patricia Le Devic5, Patrick Le Goux5, Agnes Lebrun2,5, Emmanuel Maheu5, Bertrand Moura5, Minh Nguyen2,5, Antoinette Sacchi5, Xavier Ayral5,6, Anne Blanchais2,5, Severine Neveu2,5, Maxime Dougados2,5,7 and Anna Molto2,5,7, 1Immuno-Rhumatologie, Hopital Lapeyronie, Montpellier, France, 2Université Paris René Descartes and Hôpital Cochin, Paris, France, 3Cochin Hospital, Paris Descartes University, Paris, France, 4Rhumatologie, Ch Du Mans, Le Mans, France, 5Réseau Hôpital et Ville en Rhumatologie (RHEVER) Network, Paris, France, 6Université Paris René Descartes and Hôpital Cochin, paris, France, 7INSERM (U1153): Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France., Paris, France

    Background/Purpose The current recommendations for optimal monitoring of axial spondyloarthritis (SpA) are to assess regularly disease activity. The two proposed tools comprise clinical aspects as…
  • Abstract Number: 113 • 2014 ACR/ARHP Annual Meeting

    Dermatologic Rheumatism: Our Experience with a Multidisciplinary Dermatology/Rheumatology Clinic

    Archana Sharma1, Lin A. Brown2, Dorothea Barton3 and John Mecchella4, 1Rheumatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH, 2Division of Rheumatology, Dartmouth-Hitchcock Med Ctr, Lebanon, NH, 3Dermatology, Dartmouth Hitchcock Medical Center, Lebanon, NH, 4Rheumatology, Giesel school of medicine and Dartmouth Hitchcock Medical Center, Lebanon, NH

    Background/Purpose: Multidisciplinary clinics are becoming increasingly common as a way to bring together multiple specialists to care for patients with complex diseases.  While multidisciplinary clinics commonly involve…
  • Abstract Number: 1870 • 2014 ACR/ARHP Annual Meeting

    Children and Parent Satisfaction in the Pediatric Rheumatology Clinic:  Patient Orientated Quality Service Measures

    Jenny Tekano1, Lori B. Tucker2 and Audrea Chen3, 1Rheumatology, BC Children's Hospital, Vancouver, BC, Canada, 2Rheumatology, BC Children's Hospital and University of British Columbia, Vancouver, BC, Canada, 3research student, Vancouver, BC, Canada

    Background/Purpose Patient satisfaction is a multidimensional concept, and is a component of quality care. Inclusion of patient experience with care is highly relevant in improving…
  • Abstract Number: 1867 • 2014 ACR/ARHP Annual Meeting

    Mandibular Movement in Healthy Individuals from 4-17 Years of Age

    Peter Stoustrup1, Kasper Dahl Kristensen2,3, Annelise Küseler4, Thomas Klit Pedersen5,6 and Troels Herlin7, 1Section of Orthodontics, University of Aarhus, Aarhus C, Denmark, 2Section of Orthodontics, University of Aarhus, Denmark, 8000 Aarhus, Denmark, 3Specialist Oral Health Center for Western Norway, Rogaland Stavanger, Norway, 4Section of Orthodontics, Aarhus University, Aarhus, Denmark, 5Section or Orthodontics, Aarhus University, Aarhus, Denmark, 6Department of Oral and Maxillofacial Surgery, Aarhus University Hospital, Aarhus, Denmark, 7Pediatric Rheumatology Clinic, Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark

    Background/Purpose: Assessment of mandibular movement capacity is an important part of the clinical orofacial examination of patients with juvenile idiopathic arthritis (JIA). The aim of…
  • Abstract Number: 1852 • 2014 ACR/ARHP Annual Meeting

    Increased Cardiovascular Risk in Patients Recently Diagnosed with Psoriatic Arthritis: A Population-Based, Cohort Study

    Katelynn Wilton1, Floranne C. Ernste2, Cynthia S. Crowson3, Eric L. Matteson4, Hilal Maradit Kremers5 and Marta Sánchez-Menéndez6, 1Medical Scientist Training Program, Mayo Clinic Rochester, Rochester, MN, 2Division of Rheumatology, Mayo Clinic Rochester, Rochester, MN, 3Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 4Rheumatology, Mayo Clinic, Rochester, MN, 5Health Sciences Research, Mayo Clinic, Rochester, MN, 6Centro Medico de Asturias, Oviedo, Spain

    Background/Purpose: Patients diagnosed with rheumatoid arthritis and psoriatic arthritis (PsA) have an increased risk of multiple comorbidities that predispose them to cardiovascular disease (CVD). Although…
  • Abstract Number: 1834 • 2014 ACR/ARHP Annual Meeting

    Uptake of the American College of Rheumatology’s (ACR) Rheumatology Clinical Registry (RCR): Quality Measure Summary Data 

    Natalie Fisk1, Melissa Francisco2, Jinoos Yazdany3 and Salahuddin Kazi4, 1Registry, American College of Rheumatology, Atlanta, GA, 2American College of Rheumatology, Atlanta, GA, 3Medicine, University of California, San Francisco, San Francisco, CA, 4Internal Medicine/Rheumatology, UT Southwestern Medical Center, Dallas, TX

    Background/Purpose: The RCR is designed to provide ACR members with an infrastructure for quality reporting related to rheumatoid arthritis, gout, osteoarthritis, osteoporosis, and drug safety.…
  • Abstract Number: 1679 • 2014 ACR/ARHP Annual Meeting

    A Double Blind Randomized Control Trial of Oral Tadalafil in Interstitial Lung Disease of Scleroderma

    Jyoti Parida1, Alok Nath2, Zafar Neyaz3 and Vikas Agarwal1, 1Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India, 2Pulmonary Medicine, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India, 3Radiodiagnosis, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India

    Background/Purpose We conducted a single center double-blind, randomized, placebo-controlled trial to determine the effects of oral Tadalafil on lung function and health-related symptoms in patients…
  • Abstract Number: 1659 • 2014 ACR/ARHP Annual Meeting

    The Clinical Relevance of a Repeat Biopsy in Lupus Nephritis (LN) Flares

    Milagros Ricse1, Javier Narváez2, Gloria Albert1, Paula Estrada1, Sergi Heredia1, Andrea Zacarias1, Helena Borrell1, Eulalia Armengol1, Xavier Fulladosa3, Joan Torras3, Olga Capdevila4, Francesca Mitjavila4 and Joan Miquel Nolla1, 1Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain, 2Rheumatology, Hospital Universitario de Bellvitge. Barcelona. Spain, Barcelona, Spain, 3Nephrology, Hospital Universitario de Bellvitge, Barcelona, Spain, 4Internal Medicine, Hospital Universitario de Bellvitge, Barcelona, Spain

    Background/Purpose: Renal biopsy is the gold standard for assessing renal activity and hence guiding treatment. Whether a repeat renal biopsy is helpful during flares of…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology